Beyond Purdue Pharma, the Sackler family has spread their wealth through various investments. They own over $1 billion in ...

The Sackler family has used its wealth to fund education ... JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent ...

A previous version had bankruptcy court approval but was rejected last year by the U.S. Supreme Court because it protected members of the Sackler family from civil lawsuits even though none of ...

a deal that would have members of the Sackler family who own the company pay up to $7 billion. The filing is a milestone in a tumultuous legal saga that has gone on for more than five years.

The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...

The tentative deal is worth more than $7 billion. It includes the company's owners, members of the Sackler family. However, it does not give them immunity from future opioid lawsuits as the family ...

“The Sackler family has kindly agreed to remove their ... JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent ...

“The Sackler family relentlessly pursued profit at the ... In today’s increasingly fragmented world, communities value real facts and frank opinions delivered first-hand from a non-biased ...

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying ...

Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...